Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GMAB | INCY | ASND | ||
| Company | Genmab A/S ADR | Incyte Corp | Ascendis Pharma ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 26.15 | 91.54 | 220.29 | ||
| High | 27.02 | 94.13 | 231.25 | ||
| Low | 26.15 | 91.17 | 218.83 | ||
| Latest | 26.75 | 93.22 | 229.44 | ||
| Change | +0.92 | +2.89 | +11.09 | ||
| % Change | +3.56% | +3.20% | +5.08% | ||
| Volume | 591,744 | 480,650 | 304,786 | ||
| 20-Day Average Volume | 1,573,448 | 1,606,530 | 491,855 | ||
| Previous Close | 25.83 | 90.33 | 218.35 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 26.48 | 93.36 | 227.72 | ||
| 20-Day Raw Stochastic | 55.76% | 40.35% | 51.45% | ||
| 20-Day Relative Strength | 43.42 | 44.86 | 52.99 | ||
| Weighted Alpha | +29.08 | +41.98 | +53.36 | ||
| Today's Opinion | 56% Sell | 24% Sell | 88% Buy | ||
| Previous Opinion | 72% Sell | 40% Sell | 56% Buy | ||
| Last Month's Opinion | 8% Buy | 48% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.80% since 03/24/26 | +3.01% since 03/24/26 | +6.52% since 03/24/26 | ||
| Low | 25.76 on 03/30/26 | 90.08 on 03/30/26 | 215.02 on 03/30/26 | ||
| High | 27.00 on 03/31/26 | 94.00 on 03/31/26 | 237.81 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | -9.00% since 02/27/26 | -7.82% since 02/27/26 | -1.67% since 02/27/26 | ||
| Low | 24.95 on 03/20/26 | 89.25 on 03/24/26 | 212.60 on 03/24/26 | ||
| High | 29.85 on 03/02/26 | 101.00 on 03/02/26 | 248.60 on 03/03/26 | ||
| 3-Month | |||||
| %Chg | -19.84% since 12/26/25 | -6.75% since 12/26/25 | +9.86% since 12/26/25 | ||
| Low | 24.95 on 03/20/26 | 89.25 on 03/24/26 | 188.08 on 01/12/26 | ||
| High | 35.43 on 01/14/26 | 112.29 on 01/07/26 | 248.60 on 03/03/26 | ||
| 6-Month | |||||
| %Chg | -7.84% since 09/26/25 | +12.88% since 09/26/25 | +19.58% since 09/26/25 | ||
| Low | 24.95 on 03/20/26 | 82.52 on 09/29/25 | 186.05 on 10/20/25 | ||
| High | 35.43 on 01/14/26 | 112.29 on 01/07/26 | 248.60 on 03/03/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 16,595,956 | 17,976,936 | 13,606,700 | ||
| Shares Outstanding, K | 642,507 | 199,014 | 62,316 | ||
| Annual Sales | 3,720,000,000 | 5,141,240,000 | 814,760,000 | ||
| Annual Net Income | 963,000,000 | 1,286,650,000 | -258,000,000 | ||
| Last Quarter Sales | 1,058,000,000 | 1,506,840,000 | 279,270,000 | ||
| Last Quarter Net Income | 31,000,000 | 299,280,000 | -42,910,000 | ||
| 60-Month Beta | 0.94 | 0.84 | 0.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.05 on 02/17/26 | 1.80 on 02/10/26 | -0.64 on 02/11/26 | ||
| Latest Earnings Date | 05/14/26 | 05/05/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 16.66 | 15.60 | 0.00 | ||